Newtyn Management, LLC 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Newtyn Management, LLC | 4,757,403 9.700% | 657,403 (+16.03%) | Filing |
| 2024-08-16 4:05 pm Purchase | 2024-08-07 | 13G | Theravance Biopharma, Inc. TBPH | Newtyn Management, LLC | 4,100,000 8.400% | 4,100,000 (New Position) | Filing |